In conclusion, our present study suggests that both diabetes and hyperglycemia disrupt the PHDs-HIF-α signaling pathway and reprogram cellular metabolism by a mechanism involving the upregulation of p53/TIGAR and the downregulation of SIRT3. The gene discussed is TP53; the disease is Hyperglycemia.